Acro Biomedical Co's total assets for Q4 2025 were $14.10K, an increase of 226.12% from the previous quarter. ACBM total liabilities were $401.06K for the fiscal quarter, a -8.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.